TNDM Tandem Diabetes Care Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNDM

Price (delayed)

$17.505

Market cap

$1.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$1.89B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 40

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities ...

Highlights
Tandem Diabetes Care's EPS has soared by 77% YoY and by 23% from the previous quarter
The net income has soared by 76% YoY and by 22% from the previous quarter
The debt has soared by 64% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.tandemdiabetes.com
Peers: PODD ICUI DXCM DCTH

Key stats

What are the main financial stats of TNDM

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-6.74%
1 week
-2.7%
1 month
6.41%
1 year
-3.07%
YTD
-20.36%
QTD
7.33%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$1.08B
Gross profit
$609.45M
Operating income
-$25.3M
Net income
-$49.24M
Gross margin
56.6%
Net margin
-4.6%
The operating margin has soared by 88% YoY and by 45% from the previous quarter
The operating income has soared by 87% YoY and by 45% QoQ
The net margin has soared by 77% YoY and by 25% from the previous quarter
The net income has soared by 76% YoY and by 22% from the previous quarter

Price vs fundamentals

How does TNDM's price correlate with its fundamentals

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
9.02
P/S
1.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.75
Tandem Diabetes Care's EPS has soared by 77% YoY and by 23% from the previous quarter
TNDM's price to book (P/B) is 7% more than its last 4 quarters average of 9.0 and 4% more than its 5-year quarterly average of 9.3
The company's equity rose by 3.6% QoQ
The P/S is 63% lower than the 5-year quarterly average of 3.3
TNDM's revenue is up by 7% year-on-year and by 3.3% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
The return on invested capital has surged by 87% year-on-year and by 40% since the previous quarter
Tandem Diabetes Care's ROS has soared by 84% YoY and by 36% from the previous quarter
The return on assets has surged by 80% year-on-year and by 27% since the previous quarter
TNDM's ROE has soared by 70% YoY and by 23% from the previous quarter

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 13% greater than the total liabilities
The total liabilities has grown by 38% YoY
Tandem Diabetes Care's quick ratio has increased by 38% YoY
The debt has soared by 64% YoY
The company's debt to equity has surged by 61% YoY but it fell by 3.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.